Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicine, announced today the publication of foundational research demonstrating the power of its proprietary ...

Microrobots navigating bloodstream to reach and treat clots show 95 % success in lab tests, potentially transforming stroke ...

State-of-the-artfacilities support the company's growth, and discovery and development of novel therapies for cancer and inflammatory diseases -- -- ...

Despite challenges like high treatment costs, especially in developing regions, and underdiagnosis, the CAD market is expanding with the integration of digital health and precision medicine, promising ...

CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative ...

What if SA’s Olympic bid wasn’t about sports, but was the key to unlocking a decade of economic transformation? asks Johan ...

As the automotive world races towards connected, electric and software-defined vehicles, cybersecurity has emerged not just ...

Below you'll find MLA Tim McLeod and MLA Megan Patterson's Report from the Legislature for November 12, 2025. The views expressed below are solely the opinions of the authors and do not necessarily ...

BofA Securities, Inc. acted as financial advisor to Merck in this transaction and Gibson Dunn LLP as its legal advisors. Evercore and Goldman Sachs & Co. LLC acted as financial advisors to Cidara and ...

President Donald Trump made a bold promise that he’d slash energy prices in half within 12 months of taking office during his ...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced an update to the prescribing information for ELEVIDYS (delandistrogene moxeparvovec-rokl), the ...

Detailed price information for Summit Therapeu ADR (SMMT-Q) from The Globe and Mail including charting and trades.